Does health insurance coverage of office visits influence colorectal cancer testing?

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 744-747

  Varghese, Reuben K ^a   Friedman, Carol ^a   Ahmed, Faruque ^a   Franks, Adele L ^a   Manning, Marsha ^b   Seeff, Laura C ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b GENERAL MOTORS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONSULTATION; CONTROLLED STUDY; EMPLOYMENT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; PREFERRED PROVIDER ORGANIZATION; PRIORITY JOURNAL; SALARY;

COHORT STUDIES; COLORECTAL NEOPLASMS; COST SHARING; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MASS SCREENING; MIDDLE AGED; OFFICE VISITS; PREFERRED PROVIDER ORGANIZATIONS; RISK FACTORS;

EID: 16844382230     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0477     Document Type: Article

References (26)

1. American Cancer Society. Cancer facts and figures 2004. Atlanta: American Cancer Society, Inc.; 2004. p. 4.
2. Moore G. At work with the CDC: screening is key to preventing colorectal cancer. Bus Health 2001;19;40.
3. Winawer S, Fletcher R, Rex D, et al. Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update on new evidence. Gastroenterology 2003;124:544-60.
4. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin 2001;51:38-75.
5. US Preventive Services Task Force. Guide to clinical preventive services. 3rd Ced. Periodic updates. Screening for colorectal cancer. 2002.
6. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. Ann Intern Med 1993;118:1.
7. Winawer SJ, Zauber AG, O'Brien MD, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993;328:901-6.
8. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
9. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
10. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health 1995;85:840-2.
11. Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged >50 years - United States, 2001. Morb Mortal Wkly Rep 2003;52:193-6.
12. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med 2001;21:132-7.
13. Faulkner LA, Schaffler HH. The effect of health insurance coverage on the appropriate use of recommended clinical preventive services. Am J Prev Med 1997;13:453-8.
14. Solanki G, Schauffler HH. Cost sharing and the utilization of clinical preventive services. Am J Prev Med 1999;17:127-33.
15. Solanki G, Schauffler HH, Miller LS. The direct and indirect effects of cost sharing on the use of preventive services. Health Serv Res 2000;34:1331-50.
16. Friedman C, Ahmed F, Franks A, et al. Association between health insurance coverage of office visit and cancer screening among women. Med Care 2002;40:1060-7.
17. HEDIS 2004. Volume 2. Technical Specifications. National Committee for Quality Assurance.
18. Hsia J, Kemper E, Kiefe C, et al. Importance of health insurance as a determinant of cancer screening: evidence from the women's health initiative. Prev Med 2000;31:261-70.
19. Flanders WD, Rhodes PH. Large sample confidence intervals for regression, standardized risk, risk ratios, and risk differences. J Chronic Dis 1987;40:697-704.
20. SAS version 8. Cary (NC): SAS Institute.
21. Hawley ST, Levin B, Vernon SW. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect Prev 2001;25:309-18.
22. Menon U, Champion VL, Larkin GN, et al. Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program. Am J Occup Environ Med 2003;45:891-8.
23. Kiefe CI, Funkhouser E, Fouad MN, May D. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 1998;13:357-65.
24. Rosenblatt RA, Hart LG, Baldwin LM, Chan L, Schneeweiss R. Generalist role of specialty physicians: is there a hidden system of primary care? JAMA 1998;79:364-70.
25. Wynia MK, Cummins DS, VanGeest JB, Wilson IB. Physician manipulation of reimbursement rules for patients: between a rock and a hard place. JAMA 2000;283:1858-65.
26. Garnick DW, Hendricks AM, Comstock CB, Pryor DB. A guide to using administrative data for medical effectiveness research. J Outcomes Manag 1996;3:18-23.